Encore Medical Education announces publication of the Official Best of SABCS® News Highlights summarizing key trial results from the 2022 SABCS® Read more
LUCIDITY phase 3 topline data presented at CTAD for HMTM – the only oral anti-Tau therapy in late-stage development Read more
Global Citizen Forum delivers a first-of-its-kind immersive Summit in Ras Al Khaimah, UAE, aimed at ushering in a collective cultural evolution for a more inclusive world Read more
Menarini Group Presents Updated Results from Pivotal Phase 3 EMERALD Trial at the 2022 San Antonio Breast Cancer Symposium (SABCS) that Demonstrate Elacestrant’s PFS Increases with Duration of Prior CDK4/6i in ER+, HER2- in Metastatic Setting Read more
Quantiphi launches Qollective.CX, an AI-led Total Experience Transformation Platform for Enterprise Customers Read more